William M. Mendenhall
YOU?
Author Swipe
View article: Long-Term Outcomes Following Proton Therapy for Prostate Cancer in Men Ages 50 and Younger
Long-Term Outcomes Following Proton Therapy for Prostate Cancer in Men Ages 50 and Younger Open
View article: International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version)
International Consensus Guideline on Delineation of the Clinical Target Volumes at Different Dose Levels for Nasopharyngeal Carcinoma (2024 Version) Open
Amidst the challenges of diverging practices, a comprehensive consensus guideline has been devised based on updated evidence and collective agreement among international experts. This serves as a practical reference for optimal target cove…
View article: Seismic DAS observations of a large underground chemical explosion in dry tuff
Seismic DAS observations of a large underground chemical explosion in dry tuff Open
View article: The Oncological Outcome of Postoperative Radiotherapy in Patients with Node-Negative Early-Stage (T1/T2/N0) Oral Squamous Cell Carcinoma and Perineural Invasion: A Meta-Analysis
The Oncological Outcome of Postoperative Radiotherapy in Patients with Node-Negative Early-Stage (T1/T2/N0) Oral Squamous Cell Carcinoma and Perineural Invasion: A Meta-Analysis Open
Objective: To evaluate the impact of postoperative radiotherapy (PORT) on oncological outcomes in node-negative early-stage oral squamous cell carcinoma (OSCC) with perineural invasion (PNI). Methods: A systematic review and meta-analysis …
View article: Adaptive radiotherapy for head and neck cancer: Pitfalls and possibilities from the radiation oncologist's point of view
Adaptive radiotherapy for head and neck cancer: Pitfalls and possibilities from the radiation oncologist's point of view Open
Background Patients with head and neck cancer (HNC) may experience substantial anatomical changes during the course of radiotherapy treatment. The implementation of adaptive radiotherapy (ART) proves effective in managing the consequent im…
View article: Long-Term Outcomes Following Definitive or Adjuvant Proton Radiotherapy for Adenoid Cystic Carcinoma
Long-Term Outcomes Following Definitive or Adjuvant Proton Radiotherapy for Adenoid Cystic Carcinoma Open
View article: Issue Information
Issue Information Open
Corporate Responsibility & ESGESG (Environmental, Social, Governance) is essential to Wiley's mission of unlocking human potential.For over two centuries, Wiley has a history of helping the world's researchers, learners, innovators, and le…
View article: Impact of mandated drug monitoring on opioid use during highly conformal radiotherapy for oropharynx cancer
Impact of mandated drug monitoring on opioid use during highly conformal radiotherapy for oropharynx cancer Open
PDMP use was not associated with management changes in patient-reported acute pain during RT (IMRT or PT). Following highly conformal RT, few patients remained on narcotics 3 months post-RT.
View article: Radiation Therapy in the Management of Cutaneous Squamous Cell Carcinoma Metastatic to the Parotid: A 50-Year Single Institution Experience
Radiation Therapy in the Management of Cutaneous Squamous Cell Carcinoma Metastatic to the Parotid: A 50-Year Single Institution Experience Open
View article: Pediatric Esthesioneuroblastoma Treated with Proton Radiotherapy
Pediatric Esthesioneuroblastoma Treated with Proton Radiotherapy Open
View article: Strategic Operational Redesign Improves Prior Authorization Access: A Validation Study
Strategic Operational Redesign Improves Prior Authorization Access: A Validation Study Open
View article: Issue Information
Issue Information Open
Rest of World), €2555 (Europe), £2021 (UK)
View article: Issue Information
Issue Information Open
Rest of World), €2555 (Europe), £2021 (UK)
View article: Figure S5 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
Figure S5 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer Open
Lack of correlation between ctHPV16DNA clearance at week 6 and persistent/recurrent disease
View article: Figure S3 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
Figure S3 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer Open
Baseline ctHPV16DNA levels stratified by AJCC 8th edition N staging
View article: Figure S1 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
Figure S1 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer Open
Specificity, sensitivity and linearity of HPV16 dPCR assay
View article: Table S1 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
Table S1 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer Open
Primers, probes, plasmids and gBlocks used in the HPV assay
View article: Figure S2 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
Figure S2 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer Open
Multiplexed dPCR assay for non-16 HPV strains
View article: Figure S1 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
Figure S1 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer Open
Specificity, sensitivity and linearity of HPV16 dPCR assay
View article: Figure S5 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
Figure S5 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer Open
Lack of correlation between ctHPV16DNA clearance at week 6 and persistent/recurrent disease
View article: Figure S4 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
Figure S4 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer Open
Labile ctHPV16DNA clearance kinetics in patients with low ({less than or equal to}200 copies/mL) baseline ctHPVDNA levels
View article: Figure S4 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
Figure S4 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer Open
Labile ctHPV16DNA clearance kinetics in patients with low ({less than or equal to}200 copies/mL) baseline ctHPVDNA levels
View article: Table S1 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
Table S1 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer Open
Primers, probes, plasmids and gBlocks used in the HPV assay
View article: Figure S2 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
Figure S2 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer Open
Multiplexed dPCR assay for non-16 HPV strains
View article: Figure S3 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
Figure S3 from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer Open
Baseline ctHPV16DNA levels stratified by AJCC 8th edition N staging
View article: Data from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
Data from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer Open
Purpose:To identify a profile of circulating tumor human papilloma virus (HPV) DNA (ctHPVDNA) clearance kinetics that is associated with disease control after chemoradiotherapy (CRT) for HPV-associated oropharyngeal squamous cell carcinoma…
View article: Data from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer
Data from Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal Cancer Open
Purpose:To identify a profile of circulating tumor human papilloma virus (HPV) DNA (ctHPVDNA) clearance kinetics that is associated with disease control after chemoradiotherapy (CRT) for HPV-associated oropharyngeal squamous cell carcinoma…
View article: Proton Beam Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma
Proton Beam Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma Open
View article: Current Radiotherapy Considerations for Nasopharyngeal Carcinoma
Current Radiotherapy Considerations for Nasopharyngeal Carcinoma Open
Radiotherapy is the primary treatment modality for nasopharyngeal carcinoma (NPC). Successful curative treatment requires optimal radiotherapy planning and precise beam delivery that maximizes locoregional control while minimizing treatmen…
View article: The incidence of brainstem toxicity following high-dose conformal proton therapy for adult skull-base malignancies
The incidence of brainstem toxicity following high-dose conformal proton therapy for adult skull-base malignancies Open
In delivering curative-intent radiotherapy for skull-base chordoma and chondrosarcoma in adults, small volumes of the brainstem can safely receive at least 64 GyRBE with minimal risk of serious brainstem injury.